These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31944428)

  • 21. [Leprosy in The Netherlands in the period 1970-1991].
    Post E; chin-A-Lien RA; Bouman C; Naafs B; Faber WR
    Ned Tijdschr Geneeskd; 1994 Sep; 138(39):1960-3. PubMed ID: 7935946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactive perforating leprosy, erythema multiforme-like reactions, sweet's syndrome-like reactions as atypical clinical manifestations of Type 2 leprosy reaction.
    Gunawan H; Yogya Y; Hafinah R; Marsella R; Ermawaty D; Suwarsa O
    Int J Mycobacteriol; 2018; 7(1):97-100. PubMed ID: 29516895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological characteristics of leprosy reactions: 15 years experience from north India.
    Kumar B; Dogra S; Kaur I
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):125-33. PubMed ID: 15301592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BULLOUS ERYTHEMA NODOSUM LEPROSUM MANIFESTING IN THE POST PARTUM PERIOD WITH UNUSUAL FEATURES.
    Kumar B
    Lepr Rev; 2015 Sep; 86(3):298-9. PubMed ID: 26665369
    [No Abstract]   [Full Text] [Related]  

  • 25. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M; Saunderson PR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythema nodosum leprosum. Clinical evaluation studies in lepromatous leprosy.
    GUINTO RS; TOLENTINO JG; MABALAY MC
    J Philipp Med Assoc; 1962 Dec; 38():929-40. PubMed ID: 13963487
    [No Abstract]   [Full Text] [Related]  

  • 27. Frequency and extent of thickening of the nucleated epidermis in leprosy lesions.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):410-6. PubMed ID: 11332284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactions in leprosy: an epidemiological study of 386 patients in west Nepal.
    Van Brakel WH; Khawas IB; Lucas SB
    Lepr Rev; 1994 Sep; 65(3):190-203. PubMed ID: 8942150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examining ERBB2 as a candidate gene for susceptibility to leprosy (Hansen's disease) in Brazil.
    Araújo SR; Jamieson SE; Dupnik KM; Monteiro GR; Nobre ML; Dias MS; Trindade Neto PB; Queiroz Mdo C; Gomes CE; Blackwell JM; Jeronimo SM
    Mem Inst Oswaldo Cruz; 2014 Apr; 109(2):182-8. PubMed ID: 24676663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
    Santaram V; Porichha D
    Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ENL reactions in the multibacillary cases of the AMFES cohort in central Ethiopia: incidence and risk factors.
    Saunderson P; Gebre S; Byass P
    Lepr Rev; 2000 Sep; 71(3):318-24. PubMed ID: 11105490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognizing and managing the immunologic reactions in leprosy.
    Kamath S; Vaccaro SA; Rea TH; Ochoa MT
    J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Leprosy in Guadeloupe 1980-1990: development and management in the general hospital].
    Strobel M; Gros de Beler A; Arnaud JP; Sibille G
    Bull Soc Pathol Exot; 1992; 85(1):22-5. PubMed ID: 1596953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathology of the lepromatous skin biopsy.
    Massone C; Belachew WA; Schettini A
    Clin Dermatol; 2015; 33(1):38-45. PubMed ID: 25432809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histoid leprosy with erythema nodosum leprosum--a case report.
    Vasavi S; Reddy BS
    Indian J Lepr; 2012; 84(1):27-9. PubMed ID: 23077781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bullous erythema nodosum leprosum. A case report in French Guiana].
    Couppié P; Sainte-Marie D; About V; Heid E; Pradinaud R
    Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythema nodosum leprosum in subgroups of lepromatous leprosy.
    Bhargava P; Kuldeep CM; Mathur NK
    Lepr Rev; 1997 Dec; 68(4):373-5. PubMed ID: 9503874
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
    Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reaction in leprosy: acute phase reactant response during and after remission.
    Sehgal VN; Bhattacharya SN; Shah Y; Sharma VK; Gupta CK
    Int J Dermatol; 1992 Sep; 31(9):632-4. PubMed ID: 1459760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.